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Strong association of HLA-DR2 and MT1 with idiopathic membranous
nephropathy in Japan. Fifty adult Japanese patients with biopsy-proven
idiopathic membranous nephropathy (IMN) were typed for HLA-A, B,
and DR antigens, and additional B cell alloantigens designated the MT
system. The phenotype frequencies of HLA-DR2 (80.0 vs. 36.0%) and
MTI (96.0 vs. 49.5%) appeared to be significantly increased in the
patient group when compared to those of a control. There were lower
frequencies of DR4, DRw9, MT3, and MT4 in these particular patients.
The decreases of MT3 and MT4 were statistically significant but those
of DR4 and DRw9 were not. These results suggest that HLA-DR2 and
MTI antigens are related to the occurrence of IMN in the Japanese
population.
Association étroite entre HLA-DR2 et MT1 et néphropathie extra-
membraneuse idiopathique au Japon. Cinquante malades Japonais
adultes atteints d' une néphropathie extramembraneuse idiopathique
(IMN) histologiquement prouvée ont éte types pour les antigenes HLA-
A, B, et DR, et pour les alloantigènes supplémentaires des cellules B,
dCsignés Ic systéme MT. Les frCquences des phenotypes HLA-DR2
(80,0 contre 36,0%) et MTI (96,0 contre 49,5%) sont apparues significa-
tivement plus grandes dans le groupe des malades par rapport a celles
d'un groupe contrôle. II y avait des frequences de DR4, DRW9, MT3, et
MT4 plus faibles chez ces malades particuliers. Les diminutions de
MT3 et MT4 étaient significatives, mais non celles de DR4 et DRw9.
Ces résultats suggérent que les antigènes HLA-DR2 et MTI sont relies
a Ia survenue d'une IMN dans Ia population Japonaise.
Idiopathic membranous nephropathy (IMN) is a histological-
ly well-defined disease. On light microscopy glomeruli demon-
strate the uniform thickening of the capillary walls often associ-
ated with the characteristic spike in silver stains. Immunofluo-
rescence shows diffuse granular deposition of IgG and C3 along
the glomerular capillary walls. Electron microscopy indicates
diffuse electron-dense deposits on the outer side of the base-
ment membrane. The etiology and pathogenesis of IMN are yet
far from clear, but it is generally accepted that this condition
may be the consequence of immunological injury. Similar
glomerular lesions can be experimentally induced by long-
standing, repeated injections of foreign proteins in animals with
adequate immune response [1, 21. It is suggested that in the case
of human beings, unknown antigens may stimulate the forma-
tion of the immune complex in the circulation or in situ within
the glomeruli, resulting in the occurrence of IMN under the
conditions of adequate immune response.
Recently, a significant association of HLA-DR3 with IMN
has been reported in the United Kingdom [3], France [4], and
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West Germany [51. In HLA-A and B loci, increased frequencies
of B8 [4, 5] and Bl8 [3] were found in IMN patients. Further,
MT2 was significantly increased in these particular patients [5].
However, all of these reports were concerned with Caucasian
populations.
In the present paper, HLA-A, B, DR, and MT antigens were
studied to investigate an aspect of the genetic predisposition in
Japanese patients with IMN. The results showed that pheno-
type frequencies of HLA-DR2 and MTI antigens were signifi-
cantly higher in the patient group. In addition, the role of HLA-
DR2 in the occurrence of IMN in the Japanese will be discussed
from the aspect of immune response.
Methods
Patients. Fifty unrelated Japanese patients with IMN became
the subjects of this study. The diagnosis of IMN was made
according to the histological criteria of Ehrenreich and Churg
[6]. None of the patients exhibited systemic lupus erythemato-
sus, diabetes mellitus, hepatitis, syphilis, malignancy and
known exposure to heavy metals (gold, mercury, and so forth)
or drugs (probenecid, penicillamine, and so forth).
The clinicopathological features of these patients are shown
in Table I. At the time of renal biopsy diagnosis, the mean age
was 43.2 10.4 years. Twenty-one patients were male and 29
were female. The phenotype frequencies of all patients were
compared to those in the healthy Japanese population and then
analyzed.
To analyze the correlation between the distribution of HLA
antigens and clinicopathological features, the 50 patients were
divided by four different criteria into two or three groups. The
frequencies of HLA antigens were compared in a separate
grouping. The four criteria are:
(1) Nephrotic group (proteinuria 3.5 glday and total protein
<6.0 g/dl, N = 39) versus non-nephrotic group (N = 11).
(2) Normal renal function group (Ccr 80 mI/mm at Bx, N =
36) versus renal dysfunction group (N = 14).
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Number of total patients
Mean age, years
range
Sex, male/female
Total duration of the disease, months
Hypertension, case (%) (150/90 mm Hg or more)
With nephrotic syndrome, case (%)
Without nephrotic syndrome
Renal function at renal biopsy
Mean Cçr, mi/mm
Cr 80, case (%)
Cr < 80
Histological severity
Mild, case (%)
Moderate
Severe
Response to steroid therapy
Number of selected patientsh
Responsive, case (%)
Non-responsive
Histological severity was defined by the thickening of the capillary
walls on PAS stain in light microscopy.
h Thirty-two patients were selected from all patients, who had
nephrotic syndrome and could be observed for more than 1 year after
the initiation of steroid therapy, and divided into two groups, respon-
sive and non-responsive.
(3) Histologically mild group (N = 16) versus moderate group
(N = 22) versus severe group (N = 12). Histological severity
was determined by the thickening of the capillary walls on PAS
stain in light microscopy according to the criteria of Kobayashi
et a! [7].
(4) Steroid responsive group (N = 19) versus non-responsive
group (N = 13). From the 50 patients, 32 patients were selected,
who had nephrotic syndrome and could be observed for more
than 1 year after the initiation of steroid therapy. These patients
were divided into two groups, steroid responsive group (less
than I glday of proteinuria within the first year after the
initiation of steroid therapy) and non-response group.
HLA-typing and statistical analyses. The HLA-A, B, DR,
and MT antigens were determined by the standard microlym-
phocyte toxicity test of Mittal et al [8]. B cells for DR and MT
typing were separated by a nylon wool column [9]. Antisera,
defining 16 A, 28 B, 9 DR, and 4 MT antigens were obtained
from Dr. P. I. Terasaki of the University of California Los
Angeles Tissue Typing Laboratory. The frequencies of normal
control in HLA-A, B, and DR loci were those referred to in the
report of Baur and Danilovs included in the 8th International
Histocompatibility Workshop [101. We took normal control
frequencies from our own laboratory for the MT system.
Statistical analyses were performed by the x2 method and
Fisher's exact test. To avoid a false positive, all x2 analyses
were corrected according to Yates' method. Further, P values
were multiplied by 57, which was the total number of antigens
(corrected P) according to the method of Svejgaard et al [11].
We considered it to be statistically significant if the corrected P
value (Pc) was less than 0.05.
Results
so Table 2 represents the phenotype frequencies of HLA-A, B,
DR, and MT antigens in the patient group as well as in the
43.2 10.4 national control. There were much higher frequencies of DR2
27—72 and MTI in the patient group than those in the control group.
21/29 Both differences between the two were statistically significant(DR2: 80.0 vs. 36.0%, Pc < 6.9 x l08, RR 7.12; MTI: 96.0
67.2 54.2 vs. 49.5%, Pc < 2.8 x l0, RR = 24.47). MT3 and MT4 were
decreased significantly in the patient group (MT3: 22.0 vs.
11(22.0%) 66.0%, Pc <4.5 x 1O, RR = 0.15; MT4: 24.0 vs. 63.1%, Pc <39 (78.0%)
11(22.0%) 7.3 x iO, RR = 0.18). HLA-DR4 and DRw9 were also less
frequent in the patients than in the control group, but the
differences were not statistically significant (DR4: 18.0 vs.
92.4 21.5 41.4%, Pc < 0.11, RR = 0.31; DRw9: 2.0 vs. 23.0%, Pc <
0.053, RR = 0.07). In the HLA-A and B loci, antigens did not
show any significant differences between the two groups.
The frequencies of HLA-B8, B18, and DR3, regarded to have
16 (32.0%) an association with IMN in Caucasian populations, were very
2 (4.) low in both the patient and the control groups in the Japanesepopulation (patient vs. control: B8, 0.0 vs. 0.2%; Bl8, 0.0 vs.
0.0%; DR3, 0.0 vs. 3.2%).
32 As shown in Table 3, the difference of clinicopathological
19 (59.4%) features did not affect the frequencies of each HLA antigen
except for a slight decreased tendency of DR2 in the steroid
non-responsive group (61.5%) compared to the responsive
group (84.2%). But this difference was far from the statistical
significance (P = 0.15, Fisher's exact test).
Discussion
The results of this study indicated a significant increase in the
phenotype frequencies of HLA-DR2 and MTI, and a decrease
in those of MT3 and MT4. There was a tendency toward low
frequencies of DR4 and DRw9, but these differences did not
reach a statistical significance.
From the United Kingdom, Klouda et al [3] reported that
there was a strong association between IMN and HLA-DR3 (N
= 32, 75.0 vs. 20.0%, Pc = 1.4 x l0-, RR = 12.0). Two other
reports from France [41 and West Germany [5] also found a
significant increase of DR3 in patients with IMN. Similarly,
Garavoy [12] reported in a joint report of the 8th International
Histocompatibility Workshop that among Caucasian patients
with IMN, the frequency of DR3 elevated in the United
Kingdom (N = 55, 73 vs. 21%, Pc <0.001, RR = 8.7), West
Germany (N = 21,78 vs. 21%, Pc <0.001, RR = 13) and Spain
(N = 39,67 vs. 21%, Pc <0.001, RR 7.5). In the same report,
however, a significant increase of DR3 was not observed in
France, Eastern Europe, Scandinavia, or the United States in
rather small sample populations.
In HLA-A, B, and C antigens, Klouda et al [3] found an
increase in the frequencies of Al, B8, and B18, and lower
frequencies in A2 and B12. But only the increase of B18 was
statistically significant (22.9 vs. 5.7%, Pc <0.024, RR = 5.0).
They explain the increase of B8 and B18 by their linkage
disequilibrium with DR3 and the increase of Al by its linkage
disequilibrium with B8. Le Petit, Laurent, and Berthoux [4]
from France and Muller et al [5] from West Germany found a
statistically significant increase of HLA-B8. Garavoy [12] also
reported in the joint report that HLA-B8, Bl8, Cw5, and Cw6
appeared to be significantly increased in the overall data of the
United Kingdom, West Germany, France, Spain, and the
Table 1. Patient profile of membranous nephropathy
Membranous nephropathy and HLA antigens
Table 2. HLA-A, B DR, and MT phenotype frequencies in the patients with IMN and a control group
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Groups N DR2 MTI
Nephrotic G
Nonnephrotic G
Normal renal function G
Renal dysfunction G
Histologically mild G
Moderate G
Severe G
Steroid responsive G
Nonresponsive G
11
36
14
16
22
12
19
13
NS'81.8%'
77.8% 'NS85.7%' '
68.8%
86.4% (NS)
83.3%
84.2% NSa)61.5%'
NS90.9%
NS100.0%
87.5%
100.0% (NS)
100.0%
100.0% (NS)92.3%
a Fisher's exact test showed that P = 0.15 and RR = 3.33.
United States, when compared to control values obtained by
pooling all normal Caucasian phenotypes. However, when
for comparison, only Bl8 in Spain maintained a statistical
significance (Pc < 0.05).
In the MT and MB systems, Muller et al [5] first reported a
strong association of IMN with MT2 (N = 21, 86 vs. 53%, P =
0.014, RR = 5.4). In the joint report of the 8th International
Histocompatibility Workshop, the frequency of MT2 in the
total number of Caucasian patients also demonstrated a signifi-
cant increase compared to a normal control group (N = 161, 68
vs. 53%, Pc < 0.05, RR = 1.86). In the individual countries, the
two groups of West Germany (N = 18, 94 vs. 53%, Pc <0.01,
RR = 15) and the United States (N = 33, 79 vs. 53%, Pc <0.04,
RR = 3.8) found a significant increase of MT2 among the
patients. Although no significant increase in the MB system was
discernible in the overall data, in the individual countries, MB2
was elevated in the United Kingdom, West Germany, and
Spain, as could be expected because MB2 included DR3.
Antigens Control Patients Antigens Control Patients
HLA-A locus N = 949 N = 50 HLA-B locus N = 950 N = 50
A 1 1.1 0.0 Bw50 0.0 NT
A 2 43.2 50.0 BwSl 15.9 24.0
A 3 1.1 2.0 Bw52 20.5 6.0
All 17.2 18.0 Bw53 0.2 0.0
Aw23 1.1 0.0 Bw54 14.1 4.0
Aw24 58.5 54.0 Bw55 5.8 8.0
A25 0.1 2.0 Bw56 2.2 0.0
A26 18.7 26.0 Bw57 0.0 NT
A28 1.1 0.0 Bw58 1.7 4.0
A29 0.4 0.0 Bw59 4.2 2.0
Aw30 0.3 2.0 Bw60 12.7 16.0
Aw3l 15.3 8.0 Bw6l 16.8 18.0
Aw32 0.1 0.0 Bw62 16.7 24.0
Aw33 13.1 10.0 Bw63 0.4 NT
Aw34 1.9 0.0 8w57 2.8 NT
Aw36 0.5 0.0 8w58 2.6 NT
Aw43 0.0 NT 8w66 0.0 NT
HLA-B locus N = 950 N = 50 HLA-DR locus N = 884 N = 50
B 7 11.4 10.0 DR 1 12.2 12.0
B 8 0.2 0.0 DR 2* 36.0 80.0
B13 4.0 2.0 DR 3 3.2 0.0
B14 0.2 0.0 DR 4** 41.4 18.0
B18 0.0 0.0 DR 5 4.3 4.0
B27 0.8 0.0 DRw6 9.1 NT
Bw35 14.1 16.0 DR6Y 23.8 10.0
B37 1.1 0.0 DR 7 1.0 2.0
Bw38 0.4 2.0 DRw8 12.6 18.0
Bw39 5.7 18.0 DRw9*** 23.0 2.0
Bw4l 0.7 2.0 DRwlO 1.2 NT
Bw42 1.2 2.0 HLA-MT System N = 103 N = 50
Bw44 12.5 8.0 MT 1' 49.5 96.0
Bw45 0.3 2.0 MT 2 39.8 46.0
Bw47 0.4 0.0 MT 3" 66.0 22.0
Bw48 4.6 2.0 MT 4" 63.1 24.0
Bw49 0.6 0.0
Antigens
DR 2* 37.0 1.3 x l0— 6.9 x 10—8 7.12
DR 4** 9.8 0.0018 0.11 (NS) 0.31
DRw9*** 11.0 0.00092 0.053 (NS) 0.07
MT 1' 29.8 4.8 x l0 2.8 x I0 24.47
MT 3" 24.4 7.9 >< l0 4.5 x l0 0.15
MT 4" 19.1 1.3 x l0 7.3 x l0 0.18
P< Pc < RR
Abbreviations: NT, not tested; x2 chi-square with Yates' correction; NS, not significant; RR, relative risk.
Table 3. HLA-DR2, MTI phenotype frequencies in each group (G)
classified by clinicopathological features
control data obtained from the individual countries were used This slight discrepancy among the predominantly Caucasian
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countries regarding the association of IMN with the HLA
system may occur partially because of a bias in the selection of
patients or differences in geographical location. In any event,
however, no reports indicated an association between HLA-
DR2 and/or MTI, and IMN, in Caucasian populations.
In Japan, Tomura et al [13] most recently reported a signifi-
cant increase of DR2 (N = 50, 74.4 vs. 30.4%, Pc < 106, RR
6.5) and MTI (86.0 vs. 60.1%, Pc < 0.004, RR = 4.1), and a
significant decrease of DR4, DRw8, DRw9, MT3, and MT4.
These results were almost similar to our data.
The difference between Caucasian and Japanese patients with
IMN cannot be clearly explained but may be due to a racial
difference in the distribution of HLA antigens. Furthermore,
the possibility may exist that HLA-DR2 in Japanese and HLA-
DR3 in Caucasians possess the linkage disequilibrium with a
similar unknown gene which has a major susceptibility to IMN,
In fact, in the Japanese population there are few, if any,
individuals who have HLA-B8, B18, or DR3 antigen, as is
shown in the present paper as well. In addition, to our knowl-
edge, no disease associated with these three antigens have been
reported among the Japanese.
Meanwhile, from Japan, Sasazuki et al [14] reported that
HLA-Dw12 associated with low responsiveness to tetanus
toxoid and schistosomal antigen [15] in vitro. They speculated
about the existence of HLA-linked immune suppressive genes.
They also reported [16—18] that HLA-Dwl2 appeared to be in
strong linkage disequilibrium with HLA-DR2 in the Japanese
population, but in the Caucasian population the frequency of
DRwl2 was very low and DR2 was mostly linked to Dw2.
On the other hand, Kallenberg et al [191 observed that in
patients with scleroderma, the in vitro cellular immune re-
sponse to a-Helix pomatia hemocyanin (HPH) was significantly
depressed in the patients having both HLA-B8 and DR3 anti-
gens. Further, McCombs and Michalski [20] found in healthy
young adults that the subjects with HLA-B8 had a significantly
lower respoIse to a suboptimally stimulating concentration of
phytohemagglutinin (PHA). Nine of these eleven B8-positive
individuals also had HLA-DR3.
In experimental glomerulonephritis, Germuth and Rodriguez
[2] explained the etiology of IMN in the model of chronic serum
sickness nephritis by the fact that the low level antibody
response in the presence of a relative excess of small amounts
of antigen produced small-sized complexes that were trapped in
the glomerular capillary walls to result in membranous
nephropathy.
Ooi et al [21] observed in the Caucasian that lymphocytes
from patients with IMN produced significantly lower quantities
of IgG and 1gM than those from a control group when stimulat-
ed with pokeweed mitogen. Similarly, from Japan, Matsumoto
et al [221 found that IMN patients with nephrotic syndrome had
significantly lower response to purified protein derivative (PPD)
antigen in vivo and showed impaired lymphocyte transforma-
tion with lower concanavalin A (Con A) and PHA responses in
vitro, compared to a normal control group. Recently, they
explained that the mechanism of this low responsiveness is due
in part to the increased suppressor cell activity. They observed
the significantly increased activity of peripheral blood lympho-
cytes of IMN patients stimulated by Con A to inhibit the
proliferative response of normal allogenic lymphocytes by both
Con A and PHA [23]. These findings suggested that low
responsiveness to antigens played a role in the occurrence of
IMN both in the Caucasians and Japanese and were compatible
with several basic reports as discussed above.
In the MT system, the frequency of MTI was extremely high,
showing 96% as well as that of DR2 in the patient group. The
new Ia-like antigens of the MT system are closely associated
with various DR antigens. MT1 determinant is expressed on the
most B cells bearing specificities DRI, DR2, DRw6.l, and
DRw6.3(6Y) [24]. There is not a consensus as to whether the
MT antigens represent supertypic determinants on the DR
molecule or determinants on a molecule distinct from HLA-DR.
However, Shackelford et al [25] reported that the MTI mole-
cule was distinct from the DR2 and DRw6 molecules from the
aspect of biochemical analyses. This suggests the existence of
multiple loci in the HLA-D region, regulating the immune
response, such as the I region of the mouse. However, since, to
our knowledge, the immunological characteristics of MTI have
not yet been evaluated, the role of MTI in the occurrence of
IMN remains undetermined.
The four clinicopathological classifications did not show any
apparent difference of the HLA antigen distribution. The num-
ber of patients in each group was too small to evaluate these
results. However, from our results, it may be speculated that
IMN may be an homogeneous disease entity, differing from IgA
nephropathy [261 judging from the aspect of immunogenetical
situation.
In conclusion, there may be a definite association between
HLA-DR2 and MTI antigens, and the development of IMN in
the Japanese population. These antigens may have a linkage
disequilibrium with unknown immune suppressive genes having
a significant susceptibility to IMN, just as may be the case with
HLA-DR3 and MT2 in the Caucasian population.
Reprint requests to Dr. Y. Kobayashi, Department of Internal
Medicine, Kitasato University School of Medicine, 1-15-1 Kitasaio,
Sagamihara, Kanagawa 228, Japan
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